2023 annual financial data
Intellia Therapeutics 2023 Operating margin
Intellia Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -1,420.51%.
Operating income was -515,291,000 USD and net income was -481,192,000 USD.
Operating cash flow was -394,086,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,275,000 USD
- Operating income
- -515,291,000 USD
- Net income
- -481,192,000 USD
- Operating cash flow
- -394,086,000 USD